The Effect of Octreotide on Peritoneal Alterations Induced by High Concentration of Glucose

Carozzi S. , Nasini M.G. Calcium concentration in the peritoneal dialysis solution regulates peritoneal blast proliferation and peritoneal macrophage and lymphocyte cytokine release. Perit Dial Int 1993; 13(Suppl 2): S41–4.

Kumano K. , Schiller B. , Hjelle J.T. , Moran J. Effect of osmotic solutes on fibronectin mRNA expression in rat peritoneal mesothelial cells. Blood Purif 1996; 14(2): 165–9.

Rubin J. , Herrera A.G. , Collins D. An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1991; 18(1): 97–102.

Carozzi S. , Nasini M.G. , Schelotto C. , Caviglia P.M. , Santoni O. , Pietrucci A. A biocompatibility study on peritoneal dialysis solution bags for CAPD. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1993; 9: 138–42.

Wang T. , Ghen Y.G. , Ye R.G. , Mai W.Y. , Zhen Z.H. , Li H.Q. Enhanced expression of TGF -β1 by peritoneal macrophages in CAPD patients. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1995; 11: 11–14.

Carozzi S. , Nasini M.G. , Schelotto C. , Caviglia P.M. , Santoni O. , Barocci S. Effect of calcium and 1,25 (OH)2D3 on peritoneal immune-cell cytokine release and fibroblast proliferation in CAPD patients. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1989; 5: 111–20.

Breborowicz A. , Balaskas A. , Oreopoulos D.G. , Vas M. , Martis L. , Serkes K.D. Interactions of cells from peritoneal dialysate with mesothelial cells and fibroblast in culture. In: Khanna R. , Nolph K.D. , Prowant B.F. , Twardowski Z.J. , Oreopoulos D.G. , eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1992; 8: 7–10.

Günal A.I. , Isik A. , Çeliker H. , Eren O. , Celebi H. , Günal S.Y. Short term reduction of left ventricular mass in primary hypertrophic cardiomyopathy by octreotide injections. Heart 1996; 76: 418–21.

Grant M.B. , Wargovich T.J. , Ellis E.A. , Caballero B.S. , Mansour M. , Pepine C.J. Localisation of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. Circulation 1994; 89: 1511–17.

Parmar H. , Bogden A. , Mollard M. , De Rouge B. , Phillips R.H. , Lightman S.L. Somatostatin and somatostatin analogues in oncology. Cancer Treat Rev 1989; 16: 95–115.

Border W.A. , Noble N.A. TGF-β in kidney fibrosis: A target for gene therapy. Kidney Int 1997; 51: 1388–96.

Kovacs E.J. Fibrogenic cytokines: The role of immune mediators in the development of scar tissue. Immunol Today 1991; 12: 17–23.

Lamberts S.W. The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogues in the treatment of human pituitary tumours. Endocr Rev 1988; 9: 417–36.

Yarden Y. , Ullrich A. Growth factor receptor tyrosine kinases. Annu Rev Biochem 1988; 57: 443–78.

Cool D.E. , Andreassen P.R. , Tonks N.K. , Krebs E.G. , Fischer E.H. , Morgolis R.L. Cytokinetic failure and asynchronous nuclear division in BHK cells overexpressing truncated protein-tyrosine-phosphates. Proc Natl Acad Sci USA 1992; 89: 5422–6.

Nakamoto M. Pathogenesis of peritoneal fibrosis and peritoneal small vessel changes. Perit Dial Int 1996; 16(Suppl 1): S39–41.

Wang T. , Chen Y.G. , Ye R.G. , Li S.L. , Li H.Q. , Chen Y.X. Effect of glucose on TGF -beta 1 expression in peritoneal mesothelial cells. In: Khanna R. , ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1995; 11: 7–10.

Lamb E.J. , Cat tell W.R. , Dawnay A.B.S. In-vitro formation of advanced glycosylation end products in peritoneal dialysis fluid. Kidney Int 1995; 47: 1768–74.